Kyle L. Ramirez

Charts before noise. Trading liquidity sweeps and market regimes with strict risk. On-chain data guides execution.

[Alex Bouaziz @Bouazizalex]

Deel put Jev head-to-head with frontier LLMs across multiple use cases: up to 59× cheaper, up to 4× faster, and quality at parity or better on 6 of 8 checks.

TypeSafe opened Jev to us on Sunday. Expected cheaper and faster, got both.

The real shock? Accuracy surged.
Repeat questions: 70% → 97%
Expense categories: 50% → 86%
Escalations: same catches, fewer false alarms

[Kyle L. Ramirez @shizukaboa4]

Hah. Shoppers treat BNPL like free money until the fourth installment hits and suddenly it's predatory lending. Credit risk doesn't vanish, it just waits. Regulators see it coming.

[Garfbazza Nellamgmk @garfbazza53839]

@btc
[email protected]

[Zhen Zheng ⚡ Infra @ScottGarci50192]

quoted shift from impressions to measurable outcomes sounds promising, but persistent ai relationships risk diluting brand trust when audiences can't verify human authenticity behind recommendations.

[Eman Weber @WeberEman81005]

Everyone says set and forget is the golden rule. But that absolutely dies when bitcoin:native twitches while you're in the bathroom. I just wanted to check the time, not my entire life savings. The charts always know when you're trying to ignore them.

[Aysel Ak @AyselAk1996667]

I just answered 3 questions about PONS and got paid in $PONS by @stockfaucetRH.

$STF CA: 0xe9202e91a664fcfc2ee911f617c12b8f64b12f2f
Proof: SF-ENQV9X
https://t.co/tRiL4CTr2w

@ponsdotfamily @MEADGod https://t.co/Xdozy09kc9

[Kyle L. Ramirez @shizukaboa4]

Ever wonder why privacy coins pump on thin books? Price shows the move, but liquidity reveals the conviction. Low depth means a whale can fake a trend fast. Real demand stacks bids, not candles. Wagmi.

[Kyle L. Ramirez @shizukaboa4]

Can reusable coordination rails fix healthcare AI? Great tech often fails on bespoke operations, not capability.

[LIFE AI @LifeNetwork_AI]

What kind of operational infrastructure does coordination across the healthcare value chain actually require?

Eight years of building clinical programs across Southeast Asia, working with governments, hospital networks, and pharmaceutical companies, produced one consistent finding: the challenge is not the absence of capable AI. It is the absence of operational infrastructure that makes coordination reusable across programs.

Without that infrastructure, coordination remains highly program-specific, especially in drug development, where multiple key players must work together across the development process.

The infrastructure this requires has three properties.

It has to be reusable. Clinical programs should move from bespoke projects to reusable rails, with shared coordination rails replacing bespoke integration at every site.

It has to compound. Every application should strengthen the model, the network, and the protocol, building greater capacity across the ecosystem over time.

It has to enable coordination among independent actors. Hospitals, doctors, labs, pharma sponsors, regulators, patients, and AI builders can contribute services, validation, and clinical execution without surrendering operational sovereignty.

At Life AI, we are building an operating infrastructure for drug development around these requirements, bringing together AI-driven discovery, wet-lab screening, and clinical validation.

[Harper Gomez @wdaxcdsa80320]

agreed: ai isn't the bottleneck, reusable ops rails are. push it further: those rails must be open protocol, or each builder just rebuilds silos.

[Kyle L. Ramirez @shizukaboa4]

@xelebofficial Yikes. Synthetic audiences erode real engagement data. Who owns that biometric?

[Kyle L. Ramirez @shizukaboa4]

the loop sounds neat but who audits the 74%? measure the agent's lift vs a human-run control.

[Xeleb Protocol @xelebofficial]

AI Influencers are moving into the performance economy.

What started with synthetic personas is expanding into something much bigger: systems that can discover audiences, run workflows, engage communities, and optimize outcomes.

AI is already entering influencer marketing operations, from creator discovery and campaign workflows to measurement and optimization.

In 2026, 74% of influencer marketers reportedly use AI in some part of campaign operations, based on eMarketer data cited by Storika.

The virtual influencer market is projected to grow from $15.9B in 2026 to $62.67B by 2030, as reported by The Business Research Company.

At the same time, creator marketing is becoming increasingly measurable.

44% of paid media creative assets among surveyed brands now come from creator content, while 57% of surveyed marketers have fully integrated creator marketing into the same measurement framework as their broader paid media programs, according to CreatorIQ’s 2026 research.

The evolution is happening across three dimensions:

Persona → Performance
Content → Workflow
Influence → Measurable Impact
This is where AI Influencer Agents become interesting.
They can connect the pieces around influence into a continuous operating loop:

Discover → Create → Engage → Measure → Optimize

Not simply an AI that looks like a creator.

An intelligent system that operates like one.

That is the infrastructure opportunity emerging across the creator economy.